NCT07319156 Assessment of Upper Extremity Proprioception in Patients With Cervical Radiculopathy
| NCT ID | NCT07319156 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Marmara University |
| Condition | Cervical Radiculopathy |
| Study Type | OBSERVATIONAL |
| Enrollment | 58 participants |
| Start Date | 2025-12-20 |
| Primary Completion | 2026-12-10 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 58 participants in total. It began in 2025-12-20 with a primary completion date of 2026-12-10.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
There is no study in the current literature that systematically investigates the extent of upper-extremity proprioceptive impairment in patients with radicular neuropathic symptoms secondary to cervical disc herniation, nor its association with clinical findings. Although existing reviews emphasize proprioceptive deficits in populations with neck pain or cervical spondylosis, no studies specifically address the subgroup of cervical disc-related radiculopathy. This gap in knowledge hinders the integration of proprioceptive assessments with upper-extremity functional outcome measures in diagnostic and rehabilitative processes, suggesting a need for more specific data to guide sensory-motor training approaches. The primary aim of the present study is to assess upper-extremity proprioception in patients with cervical radiculopathy by comparing them with a healthy control group. The secondary aim is to examine the relationship between upper-extremity proprioception and clinical outcomes, including parameters such as pain and functional status.
Eligibility Criteria
Inclusion Criteria: * Being between 18 and 65 years of age * Presence of radicular pain diagnosed through clinical examination and cervical -MRI imaging Patients with cervical MRI findings demonstrating cervical disc herniation at least at one level consistent with their symptoms * Willingness to participate in the study Exclusion Criteria: * History of cervical physical therapy within the past year * Symptoms or diagnosis of upper-extremity entrapment neuropathy * Patients with documented vitamin B12 or vitamin D deficiency within the last 2 years in available medical records * History of cervical surgery or cervical trauma * History of upper-extremity surgery or trauma * Individuals with intellectual disability * Presence of major psychiatric comorbidity * Diagnosis of polyneuropathy * Diagnosis of Diabetes Mellitus * Diagnosis of fibromyalgia * Use of medications that may impair proprioception * Pregnancy * Refusal to provide informed consent
Contact & Investigator
Fatma B Akdağ, Research Assistant
PRINCIPAL INVESTIGATOR
Marmara University Faculty of Medicine ,Marmara University, Department of Physical Medicine and Rehabilitation
Frequently Asked Questions
Who can join the NCT07319156 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 65 Years, studying Cervical Radiculopathy. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07319156 currently recruiting?
Yes, NCT07319156 is actively recruiting participants. Contact the research team at fatma.betul820@gmail.com for enrollment information.
Where is the NCT07319156 trial being conducted?
This trial is being conducted at Istanbul, Turkey (Türkiye).
Who is sponsoring the NCT07319156 clinical trial?
NCT07319156 is sponsored by Marmara University. The principal investigator is Fatma B Akdağ, Research Assistant at Marmara University Faculty of Medicine ,Marmara University, Department of Physical Medicine and Rehabilitation. The trial plans to enroll 58 participants.